Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 127

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 127
---

the intellectual property that we believe is important to our business, including seeking and maintaining patent protection intended
to cover the composition of matter of our product candidates, their methods of use, their methods of production, related technologies
and other inventions. In addition to patent protection, we also rely on trade secrets to protect aspects of our business that are not
amenable to, or that we do not consider appropriate for, patent protection, including certain aspects of technical know-how.

Our commercial success
depends in part upon our ability to obtain and maintain patent and other proprietary protection for commercially important technologies,
inventions and know-how related to our business, defend and enforce our intellectual property rights, particularly our patent rights,
preserve the confidentiality of our trade secrets and operate without infringing valid and enforceable intellectual property rights of
others. We have discussed above our strategy with respect to the patent protection for each of our product candidates.

The patent positions
for companies like us are generally uncertain and can involve complex legal, scientific and factual issues. In addition, the coverage
claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted and even challenged
after issuance. As a result, we cannot guarantee that any of our product candidates will be protectable or remain protected by enforceable
patents. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction
or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. Any patents that we hold
may be challenged, circumvented or invalidated by third parties.

<div align='center'>82

Regulation</div>

Government Regulation

Government authorities at the federal, state
and local level in the United States and in other countries and jurisdictions, including UK, EU and chosen APAC countries, extensively
regulate, among other things, the research, development, testing, manufacture, pricing, reimbursement, sales, quality control, approval,
packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, post-approval monitoring and reporting
and import and export of pharmaceutical products such as those we are developing.

We, along with our CMOs, CROs and third-party
vendors, will be required to satisfy these requirements in each of the countries in which we wish to conduct studies or seek approval
or licensure of our product candidates. The processes for obtaining marketing approvals in the United States and in foreign countries
and jurisdictions, along with subsequent compliance with applicable statutes,